Page last updated: 2024-12-05

pasiniazide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16367
CHEMBL ID1496806
SCHEMBL ID865578
MeSH IDM0052902

Synonyms (93)

Synonym
isoniazid & p-aminosalicylic acid
isonicotinic acid hydrazide compound with 4-amino-salicylic acid
pasiniazide
pasiniazid
4-amino-2-hydroxy-benzoic acid; pyridine-4-carbohydrazide
4-pyridinecarboxylic acid hydrazide & 4-aminosalicylic acid
isoniazid 4-aminosalicylate
2066-89-9
KBIO1_000327
DIVK1C_000327
SPECTRUM_001721
BSPBIO_002450
IDI1_000327
SPECTRUM5_001203
NCGC00024460-03
NCGC00024460-02
KBIO3_001670
KBIOSS_002201
KBIO2_007337
KBIOGR_001606
KBIO2_002201
KBIO2_004769
SPECTRUM2_001936
SPBIO_001971
SPECTRUM4_001203
NINDS_000327
SPECTRUM3_000775
SPECTRUM1503381
NCGC00021150-01
4-amino-2-hydroxybenzoic acid; pyridine-4-carbohydrazide
HMS501A09
HMS1922C06
NCGC00021150-03
NCGC00021150-04
NCGC00021150-02
rd 328
unii-83j17cn0mn
pasiniazid [inn:dcf]
pasiniazidum [inn-latin]
83j17cn0mn ,
pasiniazidum
einecs 218-183-2
nsc 758447
pasiniazide [inn-french]
pasiniazida
pasiniazida [inn-spanish]
nsc-758447
nsc758447
pharmakon1600-01503381
S4404
CCG-39463
SCHEMBL865578
CHEMBL1496806
4-pyridinecarboxylic acid, hydrazide, mono(4-amino-2-hydroxybenzoate)
paraniazide
rd-328
isonicotinic acid hydrazide p-aminosalicylate
pasiniazid [who-dd]
pascidaber
pas-hidracida
pashain
isoniazid 4-aminosalicylate [mi]
gewo-399
isonicotinic acid hydrazide, mono(4-aminosalicylate)
parasal inh
isoniazid p-amino-salicylate
dipasic
fintozid
p-aminosalicylic acid isonicotinyl hydrazide
pasiniazid [inn]
nidrapas
CS-4569
HY-B1048
DTXSID50174700
AKOS026749897
pasiniazid, analytical standard
SR-01000000138-2
sr-01000000138
J-013511
SBI-0051819.P002
4-pyridinecarboxylic acid hydrazide 4-amino-2-hydroxybenzoate
SW199569-2
4-amino-2-hydroxybenzoic acid;pyridine-4-carbohydrazide
paraniazide;pasiniazide;isonicotinic acid hydrazide p-aminosalicylate
isonicotinohydrazide 4-amino-2-hydroxybenzoate
pasiniazid,(s)
D70306
Q27269437
AS-56163
isonicotinohydrazide4-amino-2-hydroxybenzoate
EN300-12640402
isonicotinic acid hydrazide p-*aminosalicylate
CAA06689

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"After the completion of the treatment course, the negative sputum conversion rate in V+D+M treatment protocol group was 84%, significantly higher than that in the control group (42%); the former group showed a focal absorption rate and pulmonary cavity closure rate of 83% and 66%, which were 33% and 26% respectively in the latter."( [Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].
Li, SM; Xing, BC; Zheng, XM, 2004
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency5.62340.004023.8416100.0000AID485290
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency39.81070.177814.390939.8107AID2147
Microtubule-associated protein tauHomo sapiens (human)Potency14.12540.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency23.35070.00798.23321,122.0200AID2546; AID2551
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (28.57%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]